Pharmacists in Webster Groves, Missouri


13 Pharmacists found in Webster Groves
male pharmacist

Anthony Nazzoli, PHARM D


Pharmacist
8571 Watson Rd, Webster Groves, MO 63119
314-962-5545     314-968-1704

female pharmacist

Brooke Dummerth


Pharmacist
8021 Watson Rd, Webster Groves, MO 63119
314-963-0398    

male pharmacist

Mr. Carl J Bennett, RPH


Pharmacist
8571 Watson Rd, Webster Groves, MO 63119
314-962-5545     314-968-1704



male pharmacist

David Lee Franklin, R.PH.


Pharmacist
8571 Watson Rd, Webster Groves, MO 63119
314-962-5545    

female pharmacist

Hailey Rose Finnegan, PHARMD


Pharmacist
8571 Watson Rd, Webster Groves, MO 63119
314-962-5545    

male pharmacist

Jay Zalis


Pharmacist
8571 Watson Rd, Webster Groves, MO 63119
314-962-5545    

male pharmacist

Joshua Todd Pitchford, RPH


Pharmacist
8571 Watson Rd, Webster Groves, MO 63119
314-962-5545    

female pharmacist

Lauren Bates, PHARM D


Pharmacist
8571 Watson Rd, Webster Groves, MO 63119
314-962-5545    

male pharmacist

Dr. Michael A Heltzel, PHARMD


Pharmacist
8571 Watson Rd, Webster Groves, MO 63119
314-962-5545    

male pharmacist

Rodney Bachman, PHARMD


Pharmacist
8571 Watson Rd, Webster Groves, MO 63119
314-962-5545     314-968-1704

male pharmacist

Steven J. Ortiz, PHARM D. RPH.


Pharmacist
7945 Big Bend Blvd, Webster Groves, MO 63119
314-962-1065     314-962-9215

female pharmacist

Dr. Tasha Lamping


Pharmacist
8571 Watson Rd, Webster Groves, MO 63119
314-962-5545     314-968-1704

female pharmacist

Yostena Khalil


Pharmacist
8021 Watson Rd, Webster Groves, MO 63119
314-963-0398    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.